Refine
Year of publication
Document Type
- Journal article (7778)
- Doctoral Thesis (2810)
- Book article / Book chapter (133)
- Conference Proceeding (108)
- Preprint (107)
- Working Paper (67)
- Review (43)
- Report (27)
- Master Thesis (26)
- Book (20)
Language
- English (11146) (remove)
Keywords
- Toxikologie (119)
- Medizin (99)
- inflammation (95)
- Psychologie (86)
- Biochemie (85)
- cancer (81)
- Organische Chemie (68)
- gene expression (68)
- Anorganische Chemie (66)
- Maus (64)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (1933)
- Graduate School of Life Sciences (803)
- Physikalisches Institut (601)
- Institut für Psychologie (498)
- Neurologische Klinik und Poliklinik (397)
- Medizinische Klinik und Poliklinik II (381)
- Medizinische Klinik und Poliklinik I (373)
- Institut für Organische Chemie (370)
- Institut für Anorganische Chemie (356)
- Institut für Molekulare Infektionsbiologie (356)
- Institut für Informatik (342)
- Institut für Pharmakologie und Toxikologie (300)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (289)
- Rudolf-Virchow-Zentrum (281)
- Institut für Virologie und Immunbiologie (277)
- Institut für Geographie und Geologie (264)
- Julius-von-Sachs-Institut für Biowissenschaften (257)
- Institut für Theoretische Physik und Astrophysik (240)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (235)
- Pathologisches Institut (220)
- Institut für Pharmazie und Lebensmittelchemie (213)
- Institut für Mathematik (206)
- Klinik und Poliklinik für Nuklearmedizin (200)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (196)
- Lehrstuhl für Orthopädie (168)
- Institut für Physikalische und Theoretische Chemie (162)
- Kinderklinik und Poliklinik (161)
- Institut für Anatomie und Zellbiologie (160)
- Institut für Klinische Epidemiologie und Biometrie (155)
- Neurochirurgische Klinik und Poliklinik (151)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (148)
- Institut für Hygiene und Mikrobiologie (147)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (143)
- Institut für Humangenetik (140)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (137)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (134)
- Institut für Klinische Neurobiologie (133)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (131)
- Comprehensive Cancer Center Mainfranken (102)
- Klinik und Poliklinik für Strahlentherapie (90)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (88)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (84)
- Lehrstuhl für Biochemie (83)
- Institut für Experimentelle Biomedizin (81)
- Medizinische Fakultät (81)
- Institut für Psychologie (bis Sept. 2007) (80)
- Neuphilologisches Institut - Moderne Fremdsprachen (78)
- Frauenklinik und Poliklinik (77)
- Fakultät für Physik und Astronomie (75)
- Institut Mensch - Computer - Medien (72)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (70)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (67)
- Physiologisches Institut (64)
- Institut für Sportwissenschaft (61)
- Institut für Funktionsmaterialien und Biofabrikation (55)
- Betriebswirtschaftliches Institut (51)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (50)
- Volkswirtschaftliches Institut (50)
- Center for Computational and Theoretical Biology (49)
- Institut für deutsche Philologie (48)
- Institut für Medizinische Strahlenkunde und Zellforschung (47)
- Urologische Klinik und Poliklinik (47)
- Augenklinik und Poliklinik (45)
- Institut für Klinische Biochemie und Pathobiochemie (40)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (40)
- Lehrstuhl für Molekulare Psychiatrie (39)
- Graduate School of Science and Technology (37)
- Fakultät für Biologie (35)
- Fakultät für Chemie und Pharmazie (32)
- Institut für Kulturwissenschaften Ost- und Südasiens (27)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (27)
- Institut für Politikwissenschaft und Soziologie (25)
- Poliklinik für Zahnärztliche Prothetik (21)
- Institut für Allgemeinmedizin (19)
- Institut für Geologie (18)
- Institut für Mineralogie und Kristallstrukturlehre (18)
- Institut für Psychotherapie und Medizinische Psychologie (17)
- Institut für Altertumswissenschaften (16)
- Institut für Geographie (16)
- Abteilung für Parodontologie (in der Poliklinik für Zahnerhaltung und Parodontologie) (15)
- Institut für Systemimmunologie (15)
- Institut für Rechtsmedizin (14)
- Poliklinik für Zahnerhaltung und Parodontologie (13)
- Graduate School of the Humanities (12)
- Missionsärztliche Klinik (12)
- Institut für Biblische Theologie (11)
- Institut für Klinische Transfusionsmedizin und Hämotherapie (11)
- Institut für Philosophie (10)
- Institut für Pädagogik (10)
- Universität Würzburg (10)
- Institut für Medizinische Lehre und Ausbildungsforschung (9)
- Philosophische Fakultät (Histor., philolog., Kultur- und geograph. Wissensch.) (9)
- Medizinische Klinik (bis 2004) (8)
- Poliklinik für Kieferorthopädie (8)
- Wirtschaftswissenschaftliche Fakultät (8)
- Graduate School of Law, Economics, and Society (6)
- Institut für Sonderpädagogik (6)
- Katholisch-Theologische Fakultät (6)
- Fakultät für Humanwissenschaften (Philos., Psycho., Erziehungs- u. Gesell.-Wissensch.) (5)
- Fakultät für Mathematik und Informatik (5)
- Institut für Altertumswissenschaften (bis Sept. 2007) (5)
- Institut für Evangelische Theologie und Religionspädagogik (5)
- Institut für Paläontologie (5)
- Institut für Praktische Theologie (5)
- Klinik für Anaesthesiologie (bis 2003) (5)
- Klinik und Polikliniken für Zahn-, Mund- und Kieferkrankheiten (5)
- Lehrstuhl für Silicatchemie (5)
- Neuphilologisches Institut - Moderne Fremdsprachen (bis 2007) (5)
- Sportzentrum (5)
- Institut für Internationales Recht, Europarecht und Europäisches Privatrecht (4)
- Abteilung für Forensische Psychiatrie (3)
- Institut für Anglistik und Amerikanistik (3)
- Institut für Geschichte der Medizin (3)
- Juristische Fakultät (3)
- Fachgruppe Didaktik der Biologie (2)
- Institut für Geschichte (2)
- Institut für Gesellschafts-, Steuer- und Arbeitsrecht (2)
- Institut für Musikforschung (2)
- Institut für Orientalische Philologie (2)
- Institut für Systematische Theologie (2)
- Institut für medizinische Datenwissenschaften (2)
- Medizinische Poliklinik (bis 2004) (2)
- Botanischer Garten (1)
- Graduate Schools (1)
- Institut für Bürgerliches Recht und Zivilprozessrecht (1)
- Institut für Historische Theologie (1)
- Institut für Kulturwissenschaften Ost- und Südasiens (bis Sept. 2007) (1)
- Institut für Politische Wissenschaft (1)
- Klinik und Poliklinik für Haut- und Geschlechtskrankheiten (bis 2003) (1)
- Krankenhaus für Psychiatrie, Psychotherapie und Neurologie des Bezirks Unterfranken (1)
- Rechenzentrum (1)
- Zentrale Einrichtungen (1)
- Zentrum für Sprachen (1)
Schriftenreihe
- Cultural Animal Studies, Band 3 (24)
- Berichte aus der Informatik (1)
- Deuterocanonical and Cognate Literature Studies (1)
- Deuterocanonical and Cognate Literature Yearbook (1)
- International Archives of the History of Ideas / Archives internationales d’histoire des idées 242 (1)
- Methods in Molecular Biology 2533 (1)
- Methods in Molecular Biology; 2643 (1)
Sonstige beteiligte Institutionen
- VolkswagenStiftung (24)
- Johns Hopkins School of Medicine (17)
- Helmholtz Institute for RNA-based Infection Research (HIRI) (7)
- IZKF Nachwuchsgruppe Geweberegeneration für muskuloskelettale Erkrankungen (7)
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (5)
- Fraunhofer-Institut für Silicatforschung ISC (5)
- Johns Hopkins University School of Medicine (5)
- Wilhelm-Conrad-Röntgen-Forschungszentrum für komplexe Materialsysteme (5)
- Bernhard-Heine-Centrum für Bewegungsforschung (4)
- Johns Hopkins School of Medicine, Baltimore, MD, U.S. (4)
ResearcherID
- B-1911-2015 (1)
- B-4606-2017 (1)
- C-2593-2016 (1)
- D-1221-2009 (1)
- D-1250-2010 (1)
- I-5818-2014 (1)
- J-8841-2015 (1)
- M-1240-2017 (1)
- N-2030-2015 (1)
- N-3741-2015 (1)
Background:
The interaction of eukaryotic host and prokaryotic pathogen cells is linked to specific changes in the cellular proteome, and consequently to infection-related gene expression patterns of the involved cells. To simultaneously assess the transcriptomes of both organisms during their interaction we developed dual 3'Seq, a tag-based sequencing protocol that allows for exact quantification of differentially expressed transcripts in interacting pro-and eukaryotic cells without prior fixation or physical disruption of the interaction.
Results:
Human epithelial cells were infected with Salmonella enterica Typhimurium as a model system for invasion of the intestinal epithelium, and the transcriptional response of the infected host cells together with the differential expression of invading and intracellular pathogen cells was determined by dual 3'Seq coupled with the next-generation sequencing-based transcriptome profiling technique deepSuperSAGE (deep Serial Analysis of Gene Expression). Annotation to reference transcriptomes comprising the operon structure of the employed S. enterica Typhimurium strain allowed for in silico separation of the interacting cells including quantification of polycistronic RNAs. Eighty-nine percent of the known loci are found to be transcribed in prokaryotic cells prior or subsequent to infection of the host, while 75% of all protein-coding loci are represented in the polyadenylated transcriptomes of human host cells.
Conclusions:
Dual 3'Seq was alternatively coupled to MACE (Massive Analysis of cDNA ends) to assess the advantages and drawbacks of a library preparation procedure that allows for sequencing of longer fragments. Additionally, the identified expression patterns of both organisms were validated by qRT-PCR using three independent biological replicates, which confirmed that RELB along with NFKB1 and NFKB2 are involved in the initial immune response of epithelial cells after infection with S. enterica Typhimurium.
The aim of the present study was to design different dosage forms as carrier systems to deliver sorafenib to the lung of BXB-23 transgenic mice using different routes of administration. Three dosage forms were used one of them was an oil-in-water emulsion and the oral route was chosen for this experiment. The other delivery system was a liposome preparation for intratracheal instillation. In this case the oral route was considered as a control experiment. The last dosage form was PLGA microspheres. Before sorafenib administration it was important to develop a HPLC method to assess sorafenib absorption after its administration and to determine its concentrations in mouse serum. The HPLC method allowed sorafenib quantification in small volumes (30 µl) of mouse serum and tissues. The developed HPLC method was validated resulting in satisfactory selectivity, good linearity, good accuracy and precision over the concentration range examined. Sorafenib was successfully incorporated in a fat emulsion (o/w) using a traditional method resulting in a white homogenous emulsion and no particle aggregation was observed. Sorafenib exhibited antitumor activity on the lung adenoma in BXB-23 transgenic mice when administered orally (2 mg sorafenib per mouse) in the emulsion preparation. The determined effect was an approximately 29 % reduction in the tumor area of the adenoma foci and a proliferation reduction. In order to improve the pharmacological effects of sorafenib on the lung adenoma in BXB-23 mice, the targeting of sorafenib directly to the site of action (the lung) was an attractive concept. For this purpose the intratracheal route was used. Since sorafenib administration by instillation required incorporation of sorafenib in a dosage form suitable for its lipophilic nature, a liposome suspension was the second dosage form used. A lyophilization method was employed for sorafenib liposome preparation utilizing dilauroylphosphatidylcholine (DLPC) which is safe and tolerable for the lung. Incorporation of sorafenib in the liposomes did not influence the particle size and its distribution. The sorafenib liposomes showed high encapsulation efficiency, good stability at 4 °C for one month and satisfactory in vitro release properties and inhibited Raf-1 mediated activation of ERK in cell culture assay. In a pharmacokinetic experiment sorafenib loaded liposomes were instilled directly into the lung. The results revealed that a significant level of sorafenib was achieved in the lung tissues after 2 hours and then reduced after 48 h and remained nearly constant for one week. On the other hand, only traces of sorafenib were found in the mice serum up to 48 h. Subsequently, the pharmacological activity of sorafenib (1 mg per mouse) was studied when delivered in a liposomal suspension intratracheally to treat the lung adenoma of BXB-23 mice. The data of this experiment demonstrated that sorafenib intratracheal instillation resulted in a reduction of tumor area of adenoma foci (67 %) and an elevation of the percent of apoptotic cells. In contrast, prolongation of the treatment period did not further enhance sorafenib activity on the lung adenoma. This previous finding suggested a development of multidrug resistance (MDR) by the adenoma foci cells against sorafenib instillation, which was examined by immunohistochemistry staining. The percent of MDR positive cells was higher after two and three weeks sorafenib liposome instillation treatment than that after one week treatment. The last dosage form used for sorafenib was microspheres, which were prepared by emulsion-diffusion-evaporation method using biodegradable PLGA 50:50 resulting in a white lyophilized powder. The system was characterized physicochemically and revealed a good microspheres yield, high encapsulation efficiency, a homogenous particle size distribution and slow in vitro release of sorafenib. The other strategy studied in the present research project was gene delivery to target the lung bearing tumor of BXB-23 mice using a non-viral vector (polyethylenimine). Polyethylenimine (PEI) was used to investigate its efficiency in transfecting lung bearing tumor of BXB-23 mice model and its ability to transfect the adenoma foci cells. LacZ, which encodes Beta-galactosidase was used in the present study as a reporter gene and was complexed with PEI before delivered intravenously. A high LacZ expression in the alveolar region with some expression in the adenoma foci was observed. On contrary, a low LacZ expression in the alveoli and in the adenoma foci was achieved after instillation of the same polyplex intratracheally.
Radiationless energy transfer is at the core of diverse phenomena, such as light harvesting in photosynthesis\(^1\), energy-transfer-based microspectroscopies\(^2\), nanoscale quantum entanglement\(^3\) and photonic-mode hybridization\(^4\). Typically, the transfer is efficient only for separations that are much shorter than the diffraction limit. This hampers its application in optical communication and quantum information processing, which require spatially selective addressing. Here, we demonstrate highly efficient radiationless coherent energy transfer over a distance of twice the excitation wavelength by combining localized and delocalized\(^5\) plasmonic modes. Analogous to the Tavis-Cummings model, two whispering-gallery-mode antennas\(^6\) placed in the foci of an elliptical plasmonic cavity\(^7\) fabricated from single-crystal gold plates act as a pair of oscillators coupled to a common cavity mode. Time-resolved two-photon photoemission electron microscopy (TR 2P-PEEM) reveals an ultrafast long-range periodic energy transfer in accordance with the simulations. Our observations open perspectives for the optimization and tailoring of mesoscopic energy transfer and long-range quantum emitter coupling.
Optimal open-loop control, i.e. the application of an analytically derived control rule, is demonstrated for nanooptical excitations using polarization-shaped laser pulses. Optimal spatial near-field localization in gold nanoprisms and excitation switching is realized by applying a shift to the relative phase of the two polarization components. The achieved near-field switching confirms theoretical predictions, proves the applicability of predefined control rules in nanooptical light–matter interaction and reveals local mode interference to be an important control mechanism.
With an increasing variety of radiopharmaceuticals for diagnostic or therapeutic nuclear medicine as valuable diagnostic or treatment option, radiobiology plays an important role in supporting optimizations. This comprises particularly safety and efficacy of radionuclide therapies, specifically tailored to each patient. As absorbed dose rates and absorbed dose distributions in space and time are very different between external irradiation and systemic radionuclide exposure, distinct radiation-induced biological responses are expected in nuclear medicine, which need to be explored. This calls for a dedicated nuclear medicine radiobiology. Radiobiology findings and absorbed dose measurements will enable an improved estimation and prediction of efficacy and adverse effects. Moreover, a better understanding on the fundamental biological mechanisms underlying tumor and normal tissue responses will help to identify predictive and prognostic biomarkers as well as biomarkers for treatment follow-up. In addition, radiobiology can form the basis for the development of radiosensitizing strategies and radioprotectant agents. Thus, EANM believes that, beyond in vitro and preclinical evaluations, radiobiology will bring important added value to clinical studies and to clinical teams. Therefore, EANM strongly supports active collaboration between radiochemists, radiopharmacists, radiobiologists, medical physicists, and physicians to foster research toward precision nuclear medicine.
A search for muon neutrinos originating from dark matter annihilations in the Sun is performed using the data recorded by the ANTARES neutrino telescope from 2007 to 2012. In order to obtain the best possible sensitivities to dark matter signals, an optimisation of the event selection criteria is performed taking into account the background of atmospheric muons, atmospheric neutrinos and the energy spectra of the expected neutrino signals. No significant excess over the background is observed and 90% C.L. upper limits on the neutrino flux, the spin-dependent and spin-independent WIMP-nucleon cross-sections are derived for WIMP masses ranging from 50 GeV to 5 TeV for the annihilation channels WIMP + WIMP→ b\(\overline{b}\), W\(^{+}\)W\(^{−}\) and τ\(^{+}\)τ\(^{−}\).
A search for Secluded Dark Matter annihilation in the Sun using 2007-2012 data of the ANTARES neutrino telescope is presented. Three different cases are considered: a) detection of dimuons that result from the decay of the mediator, or neutrino detection from: b) mediator that decays into a dimuon and, in turn, into neutrinos, and c) mediator that decays directly into neutrinos. As no significant excess over background is observed, constraints are derived on the dark matter mass and the lifetime of the mediator.
A search for high-energy neutrino emission correlated with gamma-ray bursts outside the electromagnetic prompt-emission time window is presented. Using a stacking approach of the time delays between reported gamma-ray burst alerts and spatially coincident muon-neutrino signatures, data from the Antares neutrino telescope recorded between 2007 and 2012 are analysed. One year of public data from the IceCube detector between 2008 and 2009 have been also investigated. The respective timing profiles are scanned for statistically significant accumulations within 40 days of the Gamma Ray Burst, as expected from Lorentz Invariance Violation effects and some astrophysical models. No significant excess over the expected accidental coincidence rate could be found in either of the two data sets. The average strength of the neutrino signal is found to be fainter than one detectable neutrino signal per hundred gamma-ray bursts in the Antares data at 90% confidence level.
A highly significant excess of high-energy astrophysical neutrinos has been reported by the IceCube Collaboration. Some features of the energy and declination distributions of IceCube events hint at a North/South asymmetry of the neutrino flux. This could be due to the presence of the bulk of our Galaxy in the Southern hemisphere. The ANTARES neutrino telescope, located in the Mediterranean Sea, has been taking data since 2007. It offers the best sensitivity to muon neutrinos produced by galactic cosmic ray interactions in this region of the sky. In this letter a search for an extended neutrino flux from the Galactic Ridge region is presented. Different models of neutrino production by cosmic ray propagation are tested. No excess of events is observed and upper limits for different neutrino flux spectral indices Γ are set. For Γ=2.4 the 90% confidence level flux upper limit at 100 TeV for one neutrino flavour corresponds to Φ\(^{1f}_{0}\) (100 TeV) = 2.0 · 10\(^{−17}\) GeV\(^{−1}\) cm\(^{−2}\)s\(^{−1}\)sr\(^{−1}\). Under this assumption, at most two events of the IceCube cosmic candidates can originate from the Galactic Ridge. A simple power-law extrapolation of the Fermi-LAT flux to account for IceCube High Energy Starting Events is excluded at 90% confidence level.
The main objectives of the KM3NeT Collaboration are (i) the discovery and subsequent observation of high-energy neutrino sources in the Universe and (ii) the determination of the mass hierarchy of neutrinos. These objectives are strongly motivated by two recent important discoveries, namely: (1) the high-energy astrophysical neutrino signal reported by IceCube and (2) the sizable contribution of electron neutrinos to the third neutrino mass eigenstate as reported by Daya Bay, Reno and others. To meet these objectives, the KM3NeT Collaboration plans to build a new Research Infrastructure consisting of a network of deep-sea neutrino telescopes in the Mediterranean Sea. A phased and distributed implementation is pursued which maximises the access to regional funds, the availability of human resources and the synergistic opportunities for the Earth and sea sciences community. Three suitable deep-sea sites are selected, namely off-shore Toulon (France), Capo Passero (Sicily, Italy) and Pylos (Peloponnese, Greece). The infrastructure will consist of three so-called building blocks. A building block comprises 115 strings, each string comprises 18 optical modules and each optical module comprises 31 photo-multiplier tubes. Each building block thus constitutes a three-dimensional array of photo sensors that can be used to detect the Cherenkov light produced by relativistic particles emerging from neutrino interactions. Two building blocks will be sparsely configured to fully explore the IceCube signal with similar instrumented volume, different methodology, improved resolution and